Biological
10-valent pneumococcal conjugate vaccine clinical trials
Also written PCV10.
- studies test it
- 7
- open now
- 0
- in phase 3
- 3
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
7 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 3
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
University of Oxford (2) · Epicentre (1) · London School of Hygiene and Tropical Medicine (1) · Murdoch Childrens Research Institute (1) · Westat (1) · University of Witwatersrand, South Africa (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses 10-valent pneumococcal conjugate vaccine is read from its arms, and is right about nine times in ten.
Testing it · 7
- Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)CompletedPhase 4EpicentreNCT05175014Written as PCV10 full dose
- The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan InfantsCompletedPhase 4London School of Hygiene and Tropical MedicineNCT03489018Written as PCV10
- Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, VietnamCompletedPhase 2/3Murdoch Childrens Research InstituteNCT01953510Written as PCV10
- Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant WomenCompletedPhase 2WestatNCT02717494Written as PCV-10
- Reduced PCV Dosing Schedules in South African InfantsCompletedPhase 3University of Witwatersrand, South AfricaNCT02943902Written as Pneumococcal conjugate vaccine (PCV10 ) 1+1, 6 weeks
- PCV10 Immunogenicity Study Nepal 2015CompletedPhase 4University of OxfordNCT02385513Written as 10-valent pneumococcal conjugate vaccine
- An Alternative Booster Vaccine Against Meningitis and Ear InfectionsCompletedPhase 3University of OxfordNCT01443416Written as 10-valent pneumococcal conjugate vaccine